登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：605369 证券简称：拱东医疗 公告编号：2025-033 浙江拱东医疗器械股份有限公司 关于召开2025年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： 会议召开时间：2025年10月13日（星期一）下午15:00-16:00 会议召开地点：上海证券交易所上证路演中心（网址：http://roadshow.sseinfo.com/） 会议召开方式：上证路演中心网络互动 一、说明会类型 本次投资者说明会以网络互动形式召开，公司将针对2025年半年度的经营成果及财务指标的具体情况与 投资者进行互动交流和沟通，在信息披露允许的范围内就投资者普遍关注的问题进行回答。 二、说明会召开的时间、地点 三、参加人员 董事长：施慧勇先生；董事、总经理：钟卫峰先生；独立董事：张伟坤先生；独立董事：高江伟先生； 董事会秘书：穆玲婷女士；财务负责人、副总经理：朱勇先生。 四、投资者参加方式 （一）投资者可在2025年10月13日（星期一）下午15: ...

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 浙江拱东医疗器械股份有限公司（以下简称"公司"）已于 2025 年 8 月 26 日发布公司 2025 年半年度报告，为便于广大投资者更全面深入地了解公司 2025 年半年度经营成果、财务状况，公司计划于 2025 年 10 月 13 日（星期一）下午 15:00-16:00 举行 2025 年半年度业绩说明会，就投资者关心的问题进行交流。 一、说明会类型 证券代码：605369 证券简称：拱东医疗 公告编号：2025-033 浙江拱东医疗器械股份有限公司 关于召开 2025 年半年度业绩说明会的公告 四、投资者参加方式 （一）投资者可在 2025 年 10 月 13 日（星期一）下午 15:00-16:00，通过互 联网登录上证路演中心（http://roadshow.sseinfo.com/），在线参与本次说明会， 公司将及时回答投资者的提问。 （二）投资者可于 2025 年 9 月 26 日（星期五）至 10 月 10 日（星期五）16:00 前 登 录 上 ...

Group 1 - The third meeting of the board of directors of Zhejiang Gongdong Medical Instruments Co., Ltd. was held on September 18, 2025, with all eight directors present, and the meeting complied with legal and regulatory requirements [2][3]. - The board approved the election of Shi Huiyong as the representative director to execute company affairs, with a unanimous vote of 8 in favor [3]. - The board also approved the election of members for the audit committee, including Zhang Weikun, Gao Jiangwei, and Pan Jianwei, with Zhang Weikun appointed as the committee chair [4]. Group 2 - The company held a temporary shareholders' meeting on September 18, 2025, where all resolutions were passed without any objections [11][12]. - The meeting was conducted in accordance with the Company Law and the company's articles of association, with a combination of on-site and online voting [13]. - Various management system amendments were approved, including the cancellation of the supervisory board and revisions to the company's articles of association [14]. Group 3 - The company elected Zhang Jingxiang as the employee director during the employee representative assembly on September 18, 2025, ensuring compliance with legal requirements regarding board composition [17]. - Zhang Jingxiang has a background in quality management and has held various positions within the company, contributing to his qualifications for the role [19][20].

Group 1 - The company, Gongdong Medical, announced that its third board meeting will be held on September 18, 2025, combining in-person and remote voting methods [1] - The meeting will review documents including the proposal for electing a director to represent the company in executing its affairs [1] Group 2 - The article discusses the Federal Reserve's interest rate decisions, indicating that a 25 basis point cut is considered too small while a 50 basis point cut is viewed as excessive [1] - A notable point is that a representative of Trump cast the only dissenting vote regarding the Federal Reserve's decision [1]

特此公告。 浙江拱东医疗器械股份有限公司董事会 证券代码：605369 证券简称：拱东医疗 公告编号：2025-031 浙江拱东医疗器械股份有限公司 关于选举职工董事的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 为进一步完善浙江拱东医疗器械股份有限公司（以下简称"公司"）治理结 构，根据《中华人民共和国公司法》《上市公司章程指引》等相关法律、行政法 规、规范性文件以及《公司章程》的规定，公司于 2025 年 9 月 18 日召开职工代 表大会。经与会职工代表表决，同意选举张景祥先生（简历详见附件）为公司第 三届董事会职工董事，任期自本次职工代表大会选举通过之日起至公司第三届董 事会任期届满之日止。 张景祥先生当选公司职工董事后，公司第三届董事会中兼任公司高级管理人 员以及由职工代表担任的董事人数总计未超过公司董事总数的二分之一，符合相 关法律、行政法规、规范性文件以及《公司章程》的规定。 2025 年 9 月 19 日 附件：简历 张景祥先生，1981 年 5 月出生，中国国籍，无境外永久居留权，本科学历。 2006 ...

2025年第一次临时股东大会决议公告 证券代码：605369 证券简称：拱东医疗 公告编号：2025-030 浙江拱东医疗器械股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 一、会议召开和出席情况 (一)股东大会召开的时间：2025 年 9 月 18 日 (二)股东大会召开的地点：浙江拱东医疗器械股份有限公司（以下简称"公司" 或"拱东医疗"）三楼会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 106 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 158,963,047 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股份总数的 | 72.19 | | 比例（%） | | (四)表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次股东大会由公司董事会召集，由董事长主持，董事会秘书记录，大会采 用现场投票和网络投票相结合的表决方式进行 ...

了 天册律师事务所 T T & C LAW FIRM 法律意见书 浙江天册律师事务所 关于 浙江拱东医疗器械股份有限公司 2025 年第一次临时股东大会的 法律意见书 大册律师事务所 T & C LAW FIRM 浙江省杭州市杭大路 1 号黄龙世纪广场 A 座 11 楼 310007 电话: 0571-87901111 传真: 0571-87901500 下 天册律师事务 法律意见书 浙江天册律师事务所 关于浙江拱东医疗器械股份有限公司 2025年第一次临时股东大会的 法律意见书 编号:TCYJS2025H1459 号 致:浙江拱东医疗器械股份有限公司 浙江天册律师事务所(以下简称"本所")接受浙江拱东医疗器械股份有限 公司(以下简称"拱东医疗"或"公司"的委托,指派本所律师参加公司 2025 年第一次临时股东大会,并根据《中华人民共和国证券法》(以下简称《证券法》)、 《中华人民共和国公司法》(以下简称《公司法》)和中国证券监督管理委员会关 于《上市公司股东会规则》(以下简称《股东会规则》等法律、行政法规和其他 规范性文件的要求出具本法律意见书。 在本法律意见书中,本所律师仅对本次股东大会表决程序及表决结果 ...

证券代码：605369 证券简称：拱东医疗 公告编号：2025-032 浙江拱东医疗器械股份有限公司 董事会同意选举施慧勇先生（简历见附件）为代表公司执行公司事务的董事， 并担任公司法定代表人，任期自本次董事会审议通过之日起至公司第三届董事会 任期届满之日止。 （二）审议通过了《关于选举审计委员会成员及推选召集人的议案》 第三届董事会第十七次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗 漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、董事会会议召开情况 浙江拱东医疗器械股份有限公司（以下简称"公司"）第三届董事会第十七 次会议于 2025 年 9 月 18 日在公司三楼会议室以现场结合通讯表决方式召开。全 体董事同意豁免本次会议通知时间要求。本次会议由董事长施慧勇先生主持，会 议应出席董事 8 人，实际出席董事 8 人（其中以通讯表决方式出席会议的董事 4 人）。公司监事、高级管理人员列席本次会议。本次会议的召集、召开符合有关 法律、行政法规、部门规章、规范性文件和《公司章程》的规定，决议内容合法 有效。 二、董事会会议审议情况 （一）审议通过了《关于选 ...

Group 1 - The stock price of Gongdong Medical (605369) closed at 19.42 yuan on September 5, 2025, down 2.41% from 19.9 yuan the previous week [1] - The highest intraday price for Gongdong Medical on September 1 was 19.99 yuan, while the lowest intraday price on September 5 was 19.12 yuan [1] - The current total market capitalization of Gongdong Medical is 4.282 billion yuan, ranking 86th out of 126 in the medical device sector and 3671st out of 5152 in the A-share market [1] Group 2 - Gongdong Medical announced a share reduction plan on September 5, 2025, where controlling shareholder Shi Huiyong plans to reduce his holdings by up to 4,409,858 shares, not exceeding 2% of the total share capital [2] - Taizhou Jincheng Investment Management Partnership plans to reduce its holdings by up to 2,204,929 shares, not exceeding 1% of the total share capital [2] - Shi Huiyong and Jincheng Investment are acting in concert, holding a combined 64.21% of the shares [3]

Group 1 - Huaneng Power announced that its shareholder Hunan Energy Group plans to reduce its stake by up to 20.31 million shares, not exceeding 1% of the total share capital [1] - Ankai Bus reported a production of 1,012 buses in August, a year-on-year increase of 68.06%, with sales of 773 buses, up 46.95% year-on-year [1] - Lianhuan Pharmaceutical received a drug registration certificate for Famotidine injection, classified as a Class 3 chemical drug [1][2] Group 2 - Dongrui Co. reported sales of 94,800 pigs in August, generating revenue of 160 million yuan, a month-on-month decrease of 5.48% [3] - Tiancheng Control's subsidiary received a notification for a passenger car seat assembly project, expected to start production in April 2026 [5] - ST Huluwa obtained a drug registration certificate for Cefodizime capsules, a third-generation broad-spectrum cephalosporin [6] Group 3 - Jiulong Biotech announced the resignation of its Vice Chairman and General Manager Liang Hongjun due to work adjustments [8] - Guanhua High-tech's shareholder plans to reduce its stake by up to 17.50 million shares, not exceeding 1% of the total share capital [9] - Hebei Steel received approval to issue bonds totaling up to 10 billion yuan [10] Group 4 - Yunnan Energy Investment's subsidiaries received a total of 309 million yuan in renewable energy price subsidies [12] - Zhenghong Technology reported sales of 16,800 pigs in August, with a revenue of 22.87 million yuan, showing a year-on-year increase in sales volume of 63.31% [14] - Jilin Aodong's subsidiary received a drug registration certificate for a solution used in asthma treatment [16] Group 5 - Aonong Biological reported a 26.84% year-on-year increase in pig sales volume in August, reaching 150,100 pigs [18] - Xingdesheng announced a share repurchase plan with a budget of 15 to 30 million yuan [20] - Yueyang Lin Paper's Chairman Ye Meng resigned due to work adjustments [22] Group 6 - Kangchen Pharmaceutical's controlling shareholder plans to reduce its stake by up to 4.78 million shares, not exceeding 3% of the total share capital [23] - Changchun Yidong's General Manager Liu Xiaodong resigned due to work adjustments [25] - Zhongzai Resources' subsidiary received a government subsidy of 12.75 million yuan [26] Group 7 - Tianyu Biological reported a 41.89% month-on-month increase in sales revenue from pig sales in August [27] - Changfei Optical's shareholder Draka Comteq B.V. reduced its stake from 10% to 5% [27] - Zhongchuan Technology's Chairman Wu Xingwang resigned due to work adjustments [28] Group 8 - Huakang Clean announced a successful bid for a medical service construction project valued at 131 million yuan [29] - Yuegui Co. plans to establish a wholly-owned subsidiary with a registered capital of 100 million yuan [31] - Baisheng Intelligent's Vice General Manager and Board Secretary Huang Lijun resigned for personal reasons [32] Group 9 - Jiangsu Shuntian will change its stock name to "Suhao Fashion" starting September 10, 2025 [34] - Jiahe Meikang's shareholder plans to reduce its stake by up to 1.3759 million shares, not exceeding 1% of the total share capital [35] - Heng Rui Pharmaceutical received approval for clinical trials of HRS-4729 injection [37] Group 10 - Changfei Optical's shareholder plans to reduce its stake by up to 110,000 shares, not exceeding 0.15% of the total share capital [39] - Yutong Bus reported sales of 4,260 vehicles in August, a year-on-year increase of 16.78% [40] - JinkoSolar received 646 million yuan in renewable energy subsidies in August, a 248% increase year-on-year [41] Group 11 - Beijing Lier signed a strategic cooperation agreement with SenseTime and Xiwang Technology for AI collaboration [43] - Gongdong Medical's controlling shareholder plans to reduce its stake by up to 3% [44] - Zhonghuan Hailu terminated its control change plan and resumed trading [46] Group 12 - Longzi Co. reported a tax payment of 22.27 million yuan due to a tax audit [48] - Guoguang Chain's controlling shareholder plans to reduce its stake by up to 2.99% [49] - Guoxin Technology successfully tested a new high-performance chip for automotive electronics [50] Group 13 - GF Securities reported a cumulative increase in borrowings exceeding 20% of its net assets [51] - China Construction Bank's subsidiary plans to increase capital by 3 billion yuan [52] - Jifeng Technology plans to establish a wholly-owned subsidiary with a capital of 50 million yuan [53] Group 14 - Jiantou Energy received approval for a stock issuance plan to specific investors [54] - Shanghai Laishi's executives plan to collectively increase their holdings by at least 6 million yuan [55] - Wencan Co. reported a fire incident at its subsidiary, with no casualties reported [56]